paclitaxel is a type of Active Compound and its properties as follows :-
| Dietary_product | Qty/100gram | Qty/day (Min-Max) | T_half (Min-Max) | Peak value (Min-Max) | Qty/gm_Ref | Qty/gm_Url | Qty/day_Ref | Qty/day_Url | T_half_Ref | T_half_Url | Peak value_Ref | Peak value_Url |
| Cancer tree | 107.58 (minute) | SEZGİN BAYINDIR, Z., BEŞİKCİ, A. and YÜKSEL, N. (2015). Paclitaxel-loaded niosomes for intravenous administration: pharmacokineticsand tissue distribution in rats. TURKISH JOURNAL OF MEDICAL SCIENCES, 45, pp.1403-1412. | http://journals.tubitak.gov.tr/medical/issues/sag-15-45-6/sag-45-6-33-1408-129.pdf | |||||||||
| Yew Bark | 0.25 mL | 7.98-100 (minute) | PDR for Herbal medicines. (2000) (4th ed.). U.S. | http://www.travolekar.ru/arch/Pdr_for_Herbal_Medicines.pdf |
paclitaxel is a type of Active Compound and its properties as follows :-
| Enhencer | Effect | Reference | Url |
paclitaxel is a type of Active Compound and its properties as follows :-
| Inhibitor | Effect | Ref | Url |
paclitaxel is a type of Active Compound and its properties as follows :-
| Dietary_product | Type | Temperatute | Ref_Temp | Url_Temp |
Pathway of Dietary Product
| Medicine | Mechanism | Pathway | Reference | URL |
Dietary Substance Interactions
| Medicine | Interaction | Reference | URL |
ContraIndication Dietary Substance
| Medicine | Contraindication | Reference | URL |
L |
V |